Head to Head Analysis: Rennova Health (OTCMKTS:RNVA) & Schrodinger (NASDAQ:SDGR)

Rennova Health (OTCMKTS:RNVA) and Schrodinger (NASDAQ:SDGR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Volatility and Risk

Rennova Health has a beta of 22.02, indicating that its share price is 2,102% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500.

Earnings & Valuation

This table compares Rennova Health and Schrodinger”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
Schrodinger	$255.87 million	3.48	-$103.26 million	($1.41)	-8.55

Rennova Health has higher earnings, but lower revenue than Schrodinger.

Profitability

This table compares Rennova Health and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
Schrodinger	-40.61%	-30.85%	-15.32%

Insider and Institutional Ownership

79.1% of Schrodinger shares are held by institutional investors. 55.5% of Rennova Health shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Rennova Health and Schrodinger, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
Schrodinger	1	4	4	0	2.33

Schrodinger has a consensus price target of $20.25, suggesting a potential upside of 68.05%. Given Schrodinger’s stronger consensus rating and higher probable upside, analysts clearly believe Schrodinger is more favorable than Rennova Health.

Summary

Rennova Health beats Schrodinger on 6 of the 11 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.